BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20103082)

  • 1. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.
    Caprini JA
    Am J Surg; 2010 Jan; 199(1 Suppl):S3-10. PubMed ID: 20103082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mandated quality measures and economic implications of venous thromboembolism prevention and management.
    Passman MA
    Am J Surg; 2010 Jan; 199(1 Suppl):S21-31. PubMed ID: 20103081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of venous thromboembolism in thoracic and cardiovascular surgery.
    Egawa N; Hiromatsu S; Shintani Y; Kanaya K; Fukunaga S; Aoyagi S
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):505-9. PubMed ID: 19917794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors.
    Muntz JE; Michota FA
    Am J Surg; 2010 Jan; 199(1 Suppl):S11-20. PubMed ID: 20103080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions.
    Douketis JD
    Curr Opin Pulm Med; 2008 Sep; 14(5):381-8. PubMed ID: 18664966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validation study of a retrospective venous thromboembolism risk scoring method.
    Bahl V; Hu HM; Henke PK; Wakefield TW; Campbell DA; Caprini JA
    Ann Surg; 2010 Feb; 251(2):344-50. PubMed ID: 19779324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J; Widimský J; Dulícek P
    Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep vein thrombosis prophylaxis: friend or foe.
    Rahman S
    Am J Ther; 2009; 16(4):300-3. PubMed ID: 19092638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and etiopathogenesis of deep venous thrombosis of the lower limbs].
    Bounameaux H
    Agressologie; 1990 Mar; 31(3):141-3. PubMed ID: 2240406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
    Ansell JE
    Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis of venous thromboembolism in surgical patients.
    Rawat A; Huynh TT; Peden EK; Kougias P; Lin PH
    Vasc Endovascular Surg; 2008; 42(3):205-16. PubMed ID: 18375602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism prophylaxis for the medical patient: where do we stand?
    Yavin Y; Cohen AT
    Semin Respir Crit Care Med; 2008 Feb; 29(1):75-82. PubMed ID: 18302089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
    Laporte S; Mismetti P
    Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
    Russell MW; Taylor DC; Cummins G; Huse DM
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S3-9. PubMed ID: 11822347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advancement of prophylaxis and therapy for venous thromboembolism].
    Kobayashi T
    Rinsho Byori; 2008 Jul; 56(7):589-99. PubMed ID: 18709991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.